Xianglei He
Impact in
-
- Occupational and environmental lung diseases
- Renal cell carcinoma treatment
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 9
-
- Occupational and environmental lung diseases 4
- Sarcoma Diagnosis and Treatment 3
- Renal cell carcinoma treatment 3
- Co-authors
- Guoqing Ru (15 shared papers)Ming Zhao (16 shared papers)Shibing Wang (8 shared papers)Xiaodong Teng (5 shared papers)Chen Yang (3 shared papers)Xiangmin Tong (5 shared papers)Wen Lei (2 shared papers)Yi Ying Wu (1 shared paper)
- Journals
- Diagnostic Pathology (4 papers)Cancer Biomarkers (2 papers)Nature Communications (2 papers)Disease Markers (2 papers)BMC Cancer (1 paper)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Xianglei He
53 papers receiving 874 citations
Peers
Comparison fields: 5 of 73
- Pulmonary and Respiratory Medicine 202
- Cancer Research 88
- Biomaterials 72
- Hepatology 41
- Oncology 72
Countries citing papers authored by Xianglei He
This map shows the geographic impact of Xianglei He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianglei He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianglei He more than expected).
Fields of papers citing papers by Xianglei He
This network shows the impact of papers produced by Xianglei He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianglei He. The network helps show where Xianglei He may publish in the future.
Co-authors
The 25 scholars most cited alongside Xianglei He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 160 | |
| 2 | 2022 | 114 | |
| 3 | 2017 | 44 | |
| 4 | 2014 | 42 | |
| 5 | 2016 | 40 | |
| 6 | 2023 | 39 | |
| 7 | 2015 | 37 | |
| 8 | 2016 | 35 | |
| 9 | 2017 | 23 | |
| 10 | 2018 | 23 | |
| 11 | 2017 | 21 | |
| 12 | 2020 | 21 | |
| 13 | 2017 | 19 | |
| 14 | 2021 | 19 | |
| 15 | Tubulocystic renal cell carcinoma with poorly differentiated foci is indicative of aggressive behavior: clinicopathologic study of two cases and review of the literature. | 2015 | 18 |
| 16 | 2017 | 17 | |
| 17 | 2022 | 16 | |
| 18 | 2021 | 15 | |
| 19 | 2015 | 14 | |
| 20 | 2016 | 14 |
About Xianglei He
Xianglei He is a scholar working on Hepatology, Pulmonary and Respiratory Medicine, Surgery, Pathology and Forensic Medicine and Oncology, having authored 55 papers that have together received 887 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Virus-based gene therapy research (4 papers), Occupational and environmental lung diseases (4 papers), Sarcoma Diagnosis and Treatment (3 papers), Genetic factors in colorectal cancer (3 papers), Soft tissue tumor case studies (3 papers), Renal cell carcinoma treatment (3 papers) and Salivary Gland Tumors Diagnosis and Treatment (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (202 citations), Cancer Research (88 citations), Biomaterials (72 citations), Hepatology (41 citations) and Oncology (72 citations). Xianglei He has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Guoqing Ru, Ming Zhao, Shibing Wang, Xiaodong Teng, Chen Yang, Xiangmin Tong, Wen Lei, Yi Ying Wu, Xiaozhou Mou and Wanyuan Chen. Their work appears in journals such as Diagnostic Pathology, Cancer Biomarkers, Nature Communications, Disease Markers and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.